Strategy for elucidating differentially expressed genes in leiomyomata identified by microarray technology. 2003

William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.

OBJECTIVE cDNA microarray technology identifies genes that are differentially expressed between tissues. Our previous study identified several genes that might contribute to the fibroid phenotype. We therefore sought to confirm genes involved in three distinct signal transduction pathways. METHODS Evaluation of differential mRNA and protein expression of Dlk, Frizzled-2, and CD-24 in fibroids compared with adjacent myometrium. University hospital. METHODS Five women undergoing medically indicated hysterectomy for symptomatic fibroids. METHODS Microarray analysis of up to 33000 genes, reverse transcriptase-polymerase chain reaction (RT-PCR), real-time RT-PCR, Western blot, and immunohistochemistry. METHODS Expression of mRNA transcripts and protein in fibroid compared with myometrium.A more extensive microarray confirmed differential expression of Frizzled-2 and CD-24 but did not confirm Dlk overexpression. RT-PCR and real-time PCR demonstrated equivalent Dlk mRNA expression between fibroid and myometrium (ratio, 1.02), a slight Frizzled-2 overexpression (ratio, 2.09), and robust CD-24 overexpression in fibroids (ratio, 12.35). Western blot and immunohistochemistry confirmed Frizzled-2 overexpression, but did not confirm Dlk overexpression. CONCLUSIONS Microarray technology is the first phase of tissue evaluation, but changes in gene expression must be confirmed. Confirmed genes can then be used to generate hypotheses testing their involvement in fibroid development.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007889 Leiomyoma A benign tumor derived from smooth muscle tissue, also known as a fibroid tumor. They rarely occur outside of the UTERUS and the GASTROINTESTINAL TRACT but can occur in the SKIN and SUBCUTANEOUS TISSUE, probably arising from the smooth muscle of small blood vessels in these tissues. Fibroid,Fibroid Tumor,Fibroid Uterus,Fibroids, Uterine,Fibroma, Uterine,Fibromyoma,Leiomyoma, Uterine,Fibroid Tumors,Fibroid, Uterine,Fibroids,Fibromas, Uterine,Fibromyomas,Leiomyomas,Tumor, Fibroid,Tumors, Fibroid,Uterine Fibroid,Uterine Fibroids,Uterine Fibroma,Uterine Fibromas,Uterus, Fibroid
D008562 Membrane Glycoproteins Glycoproteins found on the membrane or surface of cells. Cell Surface Glycoproteins,Surface Glycoproteins,Cell Surface Glycoprotein,Membrane Glycoprotein,Surface Glycoprotein,Glycoprotein, Cell Surface,Glycoprotein, Membrane,Glycoprotein, Surface,Glycoproteins, Cell Surface,Glycoproteins, Membrane,Glycoproteins, Surface,Surface Glycoprotein, Cell,Surface Glycoproteins, Cell
D009215 Myometrium The smooth muscle coat of the uterus, which forms the main mass of the organ. Uterine Muscle,Muscle, Uterine,Muscles, Uterine,Uterine Muscles
D003199 Computer Systems Systems composed of a computer or computers, peripheral equipment, such as disks, printers, and terminals, and telecommunications capabilities. Computer Architecture,Computer System,Computer Systems Development,Computer Systems Evaluation,Computer Systems Organization,Real Time System,Real-Time Systems,Organization, Computer Systems,Architecture, Computer,Architectures, Computer,Computer Architectures,Computer Systems Evaluations,Development, Computer Systems,Evaluation, Computer Systems,Evaluations, Computer Systems,Real Time Systems,Real-Time System,System, Computer,System, Real Time,System, Real-Time,Systems, Computer,Systems, Real Time,Systems, Real-Time,Time System, Real,Time Systems, Real
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
March 2009, Integrative zoology,
William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
June 2004, Current eye research,
William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
March 2010, Chinese medical journal,
William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
September 2015, Molecular medicine reports,
William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
May 2003, Nucleic acids research,
William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
March 2002, Chest,
William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
March 2003, Biometrics,
William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
January 2001, Journal of computational biology : a journal of computational molecular cell biology,
William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
February 2003, Cancer letters,
William H Catherino, and Cara Prupas, and John C M Tsibris, and Phyllis C Leppert, and Mark Payson, and Lynnette K Nieman, and James H Segars
November 2004, BMC genomics,
Copied contents to your clipboard!